Bioequivalence of 2 Pediatric Formulations of Fexofenadine Hydrochloride Oral Suspension.

Rauch C, Lucio L, De Fer BB, Lheritier-Barrand M

DOI: 10.1002/cpdd.1311
Published: 2023 Dec
Container: Clinical pharmacology in drug development
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cpdd.1311,
  title = {Bioequivalence of 2 Pediatric Formulations of Fexofenadine Hydrochloride Oral Suspension.},
  author = {Rauch C and Lucio L and De Fer BB and Lheritier-Barrand M},
  year = {2023},
  journal = {Clinical pharmacology in drug development},
  doi = {10.1002/cpdd.1311},
  url = {https://doi.org/10.1002/cpdd.1311}
}

RIS

TY  - JOUR
TI  - Bioequivalence of 2 Pediatric Formulations of Fexofenadine Hydrochloride Oral Suspension.
AU  - Rauch C
AU  - Lucio L
AU  - De Fer BB
AU  - Lheritier-Barrand M
PY  - 2023
JO  - Clinical pharmacology in drug development
DO  - 10.1002/cpdd.1311
UR  - https://doi.org/10.1002/cpdd.1311
ER  -

APA

C, R., L, L., BB, D. F., & M, L. (2023). Bioequivalence of 2 Pediatric Formulations of Fexofenadine Hydrochloride Oral Suspension.. Clinical pharmacology in drug development. https://doi.org/10.1002/cpdd.1311

Source records

pubmed · retrieved 2026-11-10T06:54:05.952Z